The Enterprise Value as of December 2024 (TTM) for Evaxion Biotech A/S (EVAX) is 43.84M

According to Evaxion Biotech A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 43.84M. This represents a change of 202.01% compared to the average of 14.52M of the last 4 quarters.

Evaxion Biotech A/S (EVAX) Historical Enterprise Value (quarterly & annually)

How has EVAX Enterprise Value performed in the past?

The mean historical Enterprise Value of Evaxion Biotech A/S over the last ten years is 86.95M. The current 43.84M Enterprise Value has changed 4.94% with respect to the historical average. Over the past ten years (40 quarters), EVAX's Enterprise Value was at its highest in in the March 2020 quarter at 199.43M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Evaxion Biotech A/S (EVAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Evaxion Biotech A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evaxion Biotech A/S (EVAX) Average Enterprise Value

How has EVAX Enterprise Value performed in the past?

The current Enterprise Value of Evaxion Biotech A/S (EVAX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evaxion Biotech A/S (EVAX) Enterprise Value vs. Peers

How is EVAX’s Enterprise Value compared to its peers?

Evaxion Biotech A/S’s Enterprise Value is greater than Sigilon Therapeutics, Inc. (42.21M), less than Reviva Pharmaceuticals Holdings, Inc. (77.44M), greater than ZyVersa Therapeutics, Inc. (2.57M), greater than Kiromic BioPharma, Inc. (13.26M), greater than Unicycive Therapeutics, Inc. (38.02M), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), greater than Allarity Therapeutics, Inc. (-12625909.00), greater than Virax Biolabs Group Limited (4.10M), less than Biodexa Pharmaceuticals Plc (789.80M), less than Lyell Immunopharma, Inc. (130.21M), less than Cullinan Oncology, Inc. (614.81M), less than Monte Rosa Therapeutics, Inc. (351.25M), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Revolution Medicines, Inc. (7.98B), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than Landos Biopharma, Inc. (42.62M), greater than Apexigen, Inc. (-5121682.00), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), greater than Angion Biomedica Corp. (22.43M), greater than Revelation Biosciences, Inc. (-4029924.00), greater than Zura Bio Limited (-36740010.00), greater than Phio Pharmaceuticals Corp. (-3068516.00), greater than TransCode Therapeutics, Inc. (727.36K),

Build a custom stock screener for Evaxion Biotech A/S (EVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evaxion Biotech A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evaxion Biotech A/S (EVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evaxion Biotech A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.